Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Vernalis PLC: AGM Statement
-
Dalradian intersects 0.74 metres at 82.47 g/t gold in Step-out Drilling at Curraghinalt
-
Helios and Matheson (HMNY) Prices $60M Common Stock and Warrant Offering
-
Helios and Matheson Analytics Announces Pricing of $60 Million Public Offering
-
Hexcel Corp. (HXL): Investor Day Commentary Supports FCF Upside, PT To $64 - Cannacord
-
AECOM Technology (ACM): Guidance Bump Drives PT To $40 - Cannacord
-
Blueprint Medicines (BPMC) Prices 3.7M Share Offering at $81/Sh
-
Vernalis + Daiichi Sankyo Enter Collaboration
-
Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock
-
Helios and Matheson (HMNY) Commences 'Best Efforts' Offering of Common Stock and Warrants
-
Helios and Matheson Analytics Announces Proposed Public Offering of Common Stock and Warrants
-
Canaccord Genuity Starts SailPoint Technologies Holdings (SAIL) at Hold
-
Pershing Gold Announces Bought Deal of US$6.8 Million and Private Placement of US$6.8 Million
-
Pershing Gold (PGLC) Announces $6.8M Common Stock and Warrant Bought Deal
-
Pershing Gold Announces Bought Deal of $6.8 Million
-
Blueprint Medicines (BPMC) to Offer $275M in Common Stock
-
Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock
-
AltaGas Ltd. Announces Monthly Dividend
-
Entellus Medical (ENTL) PT Raised to $24 at Canaccord Genuity Following Acquisition by Stryker (SYK)
-
bluebird bio (BLUE) PT Raised to $228 at Canaccord Genuity Following ASH Conference
-
Cubic (CUB) PT Raised to $66 at Canaccord Genuity Following Management Meeting
-
Brookfield Property Partners L.P. (BPY) Likely To Increase Bid Significantly For GGP Inc. (GGP) - Canaccord
-
Lending Club (LC) PT Lowered to $5 at Canaccord Genuity Following Investor Day
-
Edwards Lifesciences (EW) PT Raised to $140 at Canaccord Genuity, 'We Would Be Aggressive Buyers'
-
Sage Therapeutics (SAGE) PT Raised to $191 at Canaccord Genuity
-
Broadcom (AVGO): Strong Q4/17 Results, PT To $317 - Canaccord
-
Canaccord Genuity Upgrades Lululemon Athletica Inc. (LULU) to Hold, 'Innovating through the denim cycle'
-
Deckers Brands Mails Letter to Stockholders Highlighting Significant Support from Independent Experts
-
AeroVironment (AVAV) PT Raised to $50 at Canaccord Genuity, 'Full Year 2018 Guidance Looks Conservative'
-
Vernalis and Servier Achieve Research Milestone
-
Seaport Global Securities Expands Healthcare Team
-
Tyme Provides Update on At-The-Market Financing Activity
-
Canaccord Genuity Starts bluebird bio (BLUE) at Buy Noting Long-term bb2121 Potential Is Interesting
-
Canaccord Genuity Starts Bandwidth Inc. (BAND) at Buy
-
Zynerba Pharmaceuticals (ZYNE) PT Raised to $18 at Canaccord Genuity
-
Pre-Open Movers 12/01: (UQM) (FMI) (NTNX) Higher; (GCO) (ULTA) (LLNW) Lower (more...)
-
Ambarella (AMBA) PT Raised to $67 at Canaccord Genuity, Bull Case Target Remains at $100
-
Canaccord Genuity Starts Plug Power (PLUG) at Buy
-
Descartes (DSGX) PT Raised to $34 at Canaccord Genuity
-
Autodesk (ADSK): Model Shift Drives PT Cut To $135 - Canaccord
-
Broadcom Limited (AVGO) PT Raised to $313 at Canaccord Genuity; 'Positioned for Strong Long-Term Earnings & Cash Flow Generation'
-
Aegion Corporation Executives to Attend Upcoming Infrastructure Day
-
Highlights of Neptune's Investor Conference Being Held in New York Today
-
Dalradian submits mine planning application; closes C$78 million private placement
-
Dave & Buster's (PLAY) PT Lowered to $70 at Canaccord Genuity Ahead of 3Q Release
-
Canaccord Genuity Starts Altair (ALTR) at Hold, 'A Bit Too Expensive for a Buy'
-
salesforce.com (CRM) PT Raised to $130 at Canaccord Genuity
-
salesforce.com (CRM) PT Raised to $130 at Canaccord Genuity on 3Q Report; 'No Hesitation Recommending at Current Levels'
-
Quest Diagnostics (DGX) PT Lowered to $100 at Canaccord Genuity Amid CMS Cut
-
QAD Inc (QADA) PT Raised to $44 at Canaccord Genuity on 3Q Report; 'Executing Well on Model Transition... Valuation Attractive'

